Podcasts about Guerrero

In this week's mini episode, Madigan discusses the murder of Corey Ruiz, who was killed by police in Madison Wisconsin, and gives more information regarding the man who murdered Joan Sebastián Durán Guerrero. Then, she'll discuss the internet's love of Jimothy the raccoon versus society's disdain for humans with disabilities, and lastly, a pre-obituary written for Mitch McConnell that will make you chuckle. Do you have a topic that you want the show to take on?    Email ⁠⁠neighborhoodfeminist@gmail.com⁠⁠ Social media:     Instagram: @angryneighborhoodfeminist Join me on PATREON! ⁠⁠ https://www.patreon.com/angryneighborhoodfeminist⁠ Sources: https://www.nbcnews.com/news/us-news/madison-wisconsin-police-shooting-corey-ruiz-rcna588925 https://www.nbcnews.com/news/us-news/madison-wisconsin-police-fatal-shooting-rcna588818 https://www.jsonline.com/story/news/crime/2026/07/23/williamson-street-closed-after-fatal-madison-police-shooting-july-22/91020953007/ https://isthmus.com/topics/paul-heenan/ https://wisconsinwatch.org/2013/01/police-account-of-shooting-disputed/ https://apnews.com/article/ice-david-brouillette-johan-guerrero-maine-shooting-dbc30d6d59e2a95fb470afc188e125c6 https://www.bostonglobe.com/2026/07/24/metro/maine-ice-david-brouillette-hiring-shooting/ https://www.motherjones.com/politics/2026/07/what-ice-should-have-known-when-it-hired-david-brouillette-maine-shooting/ https://www.npr.org/2026/07/17/nx-s1-5897460/maine-ice-shooting-brouillette https://www.popsci.com/science/whats-jimothy-raccoon-condition/ https://disabilityjustice.org/justice-denied/dehumanization-discrimination-and-segregation/ https://www.courier-journal.com/story/opinion/columnists/gerth/2026/07/22/senator-mitch-mcconnell-lindsay-graham-trump-voting-rights-act-supreme-court-republican-party/90981848007/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Ben Lindbergh and Meg Rowley banter about Ben’s ongoing jury service and meet major leaguers Zac Thornton and Tyron Guerrero, who used to be—but also never really were?—named Zach Thornton and Tayron Guerrero, respectively. Then (35:29) they attempt to diagnose Cal Raleigh’s offensive ills, check in on Patrick Bailey’s bat, examine how the Red Sox and Phillies wound up where they were supposed to be by a very roundabout route, assess the state of trade-deadline speculation, and consider where they would want a few top trade candidates to go. Audio intro: Philip Tapley and Michael Stokes, “Effectively Wild Theme” Audio outro: Luke Lillard, “Effectively Wild Theme” Link to Meet a Major Leaguer wiki Link to Newsday on Thornton Link to Thornton’s Grand Canyon page Link to Guerrero call-up article Link to Cotillo’s Guerrero tweet Link to Guerrero name pronunciation Link to Guerrero wiki Link to MLBTR on Guerrero Link to The Land Before Time characters Link to Soroka name tweet Link to Varland name article Link to Lovelady name article Link to Stanton name decision Link to Carmona/Hernández name change Link to Jerry Gergich wiki Link to Raleigh batted-ball profile Link to Sam’s Raleigh posts Link to Raleigh’s 2025 splits Link to Raleigh’s 2026 splits Link to original Bailey discussion Link to profane, offensive Ferguson Link to hitting after IBB article 1 Link to hitting after IBB article 2 Link to hitting after IBB article 3 Link to preseason playoff odds Link to updated playoff odds Link to Breslow on the deadline Link to Crizer on the Red Sox Link to Slaten quote Link to Dan S. on managerial firings Link to BaseRuns standings Link to team batting WAR Link to team pitching WAR Link to team 2B WAR Link to The Athletic trade candidates Link to ESPN trade candidates Link to MLBTR on Arraez Link to Goodman rumor Link to MLBTR on the Goodman rumor Link to MLBTR on the Angels’ deadline Link to JKG injury article Link to Crotchfelt signing Sponsor Us on Patreon Give a Gift Subscription Email Us: podcast@fangraphs.com Effectively Wild Subreddit Effectively Wild Wiki Apple Podcasts Feed Spotify Feed YouTube Playlist Facebook Group Bluesky Account Twitter Account Get Our Merch! var SERVER_DATA = Object.assign(SERVER_DATA || {}); Source

This week on True Crime Rundown Ellyn is joined by two very special guests, Kerri and Donna, from A Paranormal Chicks podcast. Ellyn and Joey were a guest on A Paranormal Chicks episode 416 so go listen wherever you get your podcasts! This week we cover Casper O'Brien and his parents who were charged with alleged murder. Then we cover Johan Sebastián Durán Guerrero who was killed by an ICE agent in Maine. Learn more about your ad choices. Visit megaphone.fm/adchoices

The FBI just stopped investigating ICE agent shootings. A border commander confessed he lied under oath. Maine's Senate seat just got very interesting. In this episode: • FBI will no longer investigate when ICE shoots someone — DHS, the agency that employs the shooter, now decides if it was justified • 24 people shot by immigration agents since Trump returned to office, 6 are dead — nearly all were inside vehicles and were not ICE targets • Tom Homan told two lies about body cameras for ICE agents • Border Commander Greg Bovino confessed in federal court that he lied under oath about firing tear gas at peaceful protesters • Johan Durán Guerrero was killed by an ICE agent with a documented history of domestic violence and death threats against women • Maine Senate: Graham Platner is out; Bernie Sanders-endorsed Troy Jackson now likely faces Susan Collins • Trump endorsed Mike Lindell for Minnesota Governor — Lindell is registered to vote in Texas Key figures covered: Tom Homan, Greg Bovino, Johan Durán Guerrero, Troy Jackson, Susan Collins, Graham Platner, Mike Lindell, Donald Trump

This week on The Necessary Conversation, Chad, Haley, and Mary Lou enter a brave new world in which Mary Lou said she wants to abolish ICE. Let that sink in.

This week on CounterSpin: Protests are ongoing in southern Maine, where Joan Sebastián Durán Guerrero was killed by an ICE agent on July 13. The Maine Monitor says folks are “expressing rage, fear and questions about what occurred.” Protestors also showed up at Houston City Hall, calling out ICE operations there that killed Lorenzo Salgado Araujo. Houston Public Media said: Each speech inside the council chambers was echoed by the raucous chants of dozens of protestors outside who stood for hours during the public comment session, making demands for accountability and transparency. Here in Manhattan's Foley Square, one protester told NY1: “I think it's gone past the point of we need to abolish ICE. I think we need a thorough investigation and, if appropriate, trials, prosecutions.” Said another: “For me, this past week is a reminder that we should all be out here.” Corporate media are narrating this nightmare, but do their, will their questions ever go deep enough to drive actual change? Right now, the focus seems heavy on the notion that we need to “humanize” the victims of racist state violence, rather than challenge the humanity of those who enact it. (Oh, but you'll be happy to know Snopes is on top of the question of whether Joan Sebastián Durán's three-year-old daughter actually saw her father be shot to death by state agents. Don't want to get it twisted.) We talk about ICE murders, and the bigger system that encourages and absolves them, with Lauren Bonds, executive director of the National Police Accountability Project. Plus Janine Jackson takes a quick look at recent press coverage of Lindsey Graham's death and the war on Venezuela.   CounterSpin provides a critical examination of the each week's major news stories, and exposes what the mainstream media may have missed in their own coverage. Produced by the national media watch group FAIR (Fairness and Accuracy In Reporting). The post Lauren Bonds on ICE Murders appeared first on KPFA.

The Blue Jays snapped their three-game losing streak Saturday afternoon with a 1–0 victory over the Chicago White Sox. Toronto now sits at 46–52 and remains 3.5 games back of the final AL Wild Card spot as the teams prepare for the rubber match at Rogers Centre.On game preview 99 of Flight Deck, hosted by Dan Riccio, we break down Shane Bieber's best performance since joining the Blue Jays. Bieber earned his first victory of the season after throwing six scoreless innings, allowing only three hits and two walks while striking out six. Could this be the outing that finally gets Bieber's season back on track?Toronto's bullpen made the one-run lead stand up. Jeff Hoffman, Tyler Rogers and Louis Varland combined for three scoreless innings, with Varland pitching a perfect ninth to record his 20th save of the season. After the pitching staff surrendered 12 runs in the series opener, how encouraging was this complete turnaround?The offence did just enough to secure the victory. Vladimir Guerrero Jr. doubled in the fourth inning before George Springer drove him home with the game's only run. Guerrero finished with two hits and showed more signs of breaking out, but Toronto managed only five hits overall. Can the Blue Jays produce a more complete offensive performance in the series finale?We'll also look back at a special afternoon at Rogers Centre, where the Blue Jays honoured the 1992 and 1993 World Series championship teams and unveiled a new statue commemorating Joe Carter's iconic walk-off home run.Looking ahead, Trey Yesavage takes the mound against Sean Burke in Game 3 of the series. Yesavage enters with a 4–4 record, a 3.72 ERA and 69 strikeouts over 75 innings. He'll be looking to bounce back after walking seven batters and throwing only 20 strikes over 1.2 innings against San Diego in his shortest outing of the season.Burke enters at 6–4 with a 3.41 ERA, 115 strikeouts and a 1.17 WHIP over 105.2 innings. Can the Blue Jays solve one of Chicago's most reliable starters, take the series and build some momentum before beginning a four-game set against the Tampa Bay Rays?Finally, with Toronto still seven games below .500 and the trade deadline rapidly approaching, is a series victory enough to keep the Blue Jays in the buyer conversation? Or does Ross Atkins need to see an extended winning streak before committing to this roster?We finish with Dan's picks presented by bet365.LIVE every game day one hour before first pitch right here on the Blue Jays Nation YouTube channel and on Instagram @BlueJaysNation.Subscribe and turn on notifications so you never miss an episode of Flight Deck.Thanks to our partners:bet365: http://www.bet365.caTable Fare + Social: https://www.tablefoodhall.com/#BlueJays #TorontoBlueJays #MLB #BlueJaysNation #FlightDeck Hosted on Acast. See acast.com/privacy for more information.

H to the IZZO and is Yo President a Ho?! The summer of scam continues! From Mississippi’s governor turning down SNAP funds, to Jay-Z fans crashing through security, to rapper Boosie paying two MAGA-thieves for a Trump pardon that never materialized. And we’ve received your kind messages about host Andrew Gillum. We’ll playback some of your responses to last week’s episode. Join hosts Angela Rye, Bakari Sellers, and Andrew Gillum for episode 140 of Native Land Pod. FYSA HEADLINES --- NYC’s Mayor Mamdani comments on a security breach at a JAY-Z concert in New York. --- Lindsay Graham’s sister, Darline Graham Nordone, has been tapped to replace Lindsay as S.C.’s acting senator. --- E Jean Carroll has finally received $5.6 million from Trump after her successful sexual abuse and defamation case. --- Rapper Boosie Badazz paid known MAGA scammers Jacob Wohl and Jack Burkman $600K for a Trump pardon. --- Mississippi Governor Tate Reeves opted out of Summer EBT (SNAP) for the third year in a row. --- ICE officers fatally shoot Lorenzo Salgado Araujo and Johan Sebastián Durán Guerrero, two men in less than a week. --- An update from Lil Durk’s attorney, Drew Findling. Lil Durk is facing a murder-for-hire charges. LINKS AND RESOURCES Rep Ro Khanna Detained by Settlers: https://www.aljazeera.com/news/2026/7/12/detained-by-settlers-us-democrat-ro-khanna-now-faces-pro-israel-attacks Mississippi Today on Summer EBT: https://mississippitoday.org/2026/07/06/mississippi-summer-hunger-kids/ SUBMIT A QUESTION Have a question for our hosts? Send a 60-second video to @nativelandpod and they may answer it on the show! Tutorial video for submitting questions: http://www.instagram.com/reel/C5j_oBXLIg0/ We are 110 days away from the midterm elections. Welcome home y’all! —--------- We want to hear from you! Send us a video @nativelandpod and we may feature you on the podcast. Instagram X/Twitter Facebook NativeLandPod.com Watch full episodes of Native Land Pod here on YouTube. Native Land Pod is brought to you by Reasoned Choice Media. Thank you to the Native Land Pod team: Angela Rye as host, executive producer, and cofounder of Reasoned Choice Media; Andrew Gillum as host and producer, Bakari Sellers as host and producer, and Lauren Hansen as executive producer; LoLo Smith is our research producer, and Nikolas Harter is our editor and producer. Special thanks to Chris Morrow and Lenard McKelvey, co-founders of Reasoned Choice Media. Theme music created by Daniel Laurent. See omnystudio.com/listener for privacy information.

This Day in Maine for Thursday, July 16, 2026.

A mask was tyranny. An unmarked SUV is freedom.This week's episode is for the “do not comply” crowd who suddenly discovered obedience the second government force was aimed at someone else.Trump takes over primetime Thursday. Robin breaks down the speech, the spectacle, and the deadly reality underneath it Friday in:All Roads Lead to Rome: Trump Takes Primetime, ICE Takes a LifeNew episode drops Friday.Become a supporter of this podcast: https://www.spreaker.com/podcast/we-saw-the-devil-unfiltered-political-analysis--4433638/support.Website: http://www.wesawthedevil.comPatreon: http://www.patreon.com/wesawthedevilRobin's Instagram: http://www.instagram.com/robin_wstdTwitter: http://www.twitter.com/WeSawtheDevilInstagram: http://www.instagram.com/wesawthedevilpodcast.TikTok: tiktok.com/@wesawthedevilpolitics

El director de Lantia Intelligence revisa la renuncia del exfuncionario a la Fiscalía Especial en Investigación de Asuntos Relevantes, su papel en indagatorias vinculadas a Sinaloa y las polémicas que marcaron su paso por la Fiscalía capitalina.

#InviertanBienOVendan

El jefe del Instituto Nacional de Defensa Civil, Luis Enrique Vásquez Guerrero, informó que ante la inminencia del Fenómeno de El Niño ahora se tienen que hacer obras de mitigación, dado que solo quedan unos pocos meses antes del incremento de las lluvias. En declaraciones a Ampliación de Noticias, Vásquez afirmó que la declaratoria de emergencia vigente para 796 distritos en 22 departamentos permite que las autoridades de los tres niveles de gobierno reorienten sus presupuestos para ejecutar acciones que reduzcan las vulnerabilidades en sus jurisdicciones.

Jonathan Guadalupe Romero Hil desapareció el 5 de diciembre de 2018 en Acapulco, Guerrero, después de que testigos aseguraran que fue detenido por policías municipales. Durante casi siete años, su madre, Socorro Gil Guzmán, lo buscó sin descanso hasta que finalmente recibió la noticia que ninguna madre quisiera escuchar: los restos de su hijo habían sido localizados. En esta entrevista, Socorro relata la última llamada con Jonathan, las irregularidades que denuncia en la investigación, las amenazas que sufrió por exigir justicia y el dolor de encontrar a su hijo de una forma que jamás imaginó. _________________Distribuido por Genuina Media Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Headlines for July 14, 2026; “They Were Hunting for Latinos”: LULAC CEO on ICE Killing of Lorenzo Salgado Araujo in Houston; “Our Community Is Hurting”: ICE Kills 25-Year-Old Johan Sebastián Durán Guerrero in Biddeford, Maine; “Vote Her Out”: After Maine ICE Shooting, Sen. Collins Under Fire for Deciding Vote on ICE Funding; “Completely Unprecedented”: Ari Berman on Trump’s Attack on Elections Ahead of Midterms

John discusses the Trump administration ordering ICE to immediately suspend most vehicle stops nationwide following a pair of high-profile fatal shootings of motorists within less than a week. In Maine, an ICE officer shot and killed Johan Sebastián Durán Guerrero, a 26-year-old Colombian national, during an enforcement operation on Pool Street. Also, in Texas, agents in unmarked vehicles initiated a traffic stop and fatally shot 52-year-old Lorenzo Salgado Araujo while he was driving his construction crew to a job site. Then, John interviews the founder of the Turquoise & Lavender Institute for Transformation and Healing and a nationally recognized leader in racial healing and spiritual transformation - Catherine Meeks, PhD. They talk about her new book "Bridging the Rivers of Difference: A Proclamation of Unity in Resistance". Next, John welcomes back former MSNBC host, award winning Journalist, host of the Joy Reid show on YouTube, and author of the Substack Joy's House - the one and only Joy Reid. They talk about the survival of media and religion in this Trumpian world of division and hate. Then winding it up, comedians Rhonda Hansome and Keith Price team up to joke with John and listeners about the erasure of history, the ICE shootings, and Broadway.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Headlines for July 14, 2026; “They Were Hunting for Latinos”: LULAC CEO on ICE Killing of Lorenzo Salgado Araujo in Houston; “Our Community Is Hurting”: ICE Kills 25-Year-Old Johan Sebastián Durán Guerrero in Biddeford, Maine; “Vote Her Out”: After Maine ICE Shooting, Sen. Collins Under Fire for Deciding Vote on ICE Funding; “Completely Unprecedented”: Ari Berman on Trump’s Attack on Elections Ahead of Midterms

Joan Sebastian Guerrero, a 26-year-old husband and father, reportedly possessing a social security number and the legal right to work in the US, was fatally shot by federal immigration agents on the street in Maine on Monday. Guerrero is the fourth person to have been killed by ICE agents this year alone. The surge of violence is again igniting anger at Trump's aggressive immigration agenda, and the apparent lack of accountability for ICE agents. Maine Congresswoman Chellie Pingree joins the show from Washington DC to discuss.   Also on today's show: Rachel Goodman, Free Expression Special Counsel, Protect Democracy; Jocelyn Kiley, Director of Research, Pew Research Center    Learn more about your ad choices. Visit podcastchoices.com/adchoices

En este episodio de la Serie de Expertos de la Fundación de Lupus de América, nos centramos en las nuevas guías de tratamiento para el lupus eritematoso sistémico (LES) publicadas por el Colegio Americano de Reumatología (American College of Rheumatology). Nuestro invitado, el Dr. Jorge Sánchez-Guerrero, explica la importancia de estas guías para ofrecer recomendaciones basadas en evidencia orientadas a una atención personalizada del paciente, así como el proceso de elaboración y actualización de dichas guías y los cambios clave que priorizan un control óptimo de la enfermedad y la reducción del uso prolongado de corticosteroides. El Dr. Sánchez-Guerrero destaca la necesidad de la participación activa del paciente y de una buena comunicación con los profesionales de la salud para garantizar un manejo eficaz del lupus. Regístrate para recibir correos electrónicos de la Fundación de Lupus de América (LFA) cuando se publiquen nuevos episodios (en inglés): https://support.lupus.org/site/SPageNavigator/email_subscribe_expert_series.html?s_src=lupus.org&s_subsrc=TES_s9e4Conclusiones:Las nuevas directrices sobre el lupus hacen hincapié en lograr la remisión de la enfermedad y reducir el uso de esteroides para prevenir efectos secundarios irreversibles.Las directrices de tratamiento son recomendaciones, no obligaciones, y respaldan — en lugar de sustituir — el criterio clínico de su médico.El tratamiento debe adaptarse a las necesidades individuales del paciente y a las manifestaciones de la enfermedad.Las terapias biológicas e inmunosupresoras pueden ayudar a controlar la actividad de la enfermedad.La comunicación abierta y la participación activa del paciente son fundamentales para tomar decisiones eficaces sobre el tratamiento.Recursos relacionados:Pregúntele a una educadora de la salud: https://www.lupus.org/es/care-support/ask-a-health-educatorEl Centro Nacional de Recursos sobre el Lupus: https://www.lupus.org/es/resourcesEncuentra apoyo cerca de ti (en inglés): https://www.lupus.org/es/support-groupsNuevas directrices para el tratamiento del lupus (en inglés): https://rheumatology.org/press-releases/new-lupus-sle-clinical-practice-guidelines-released

U.S. Immigration and Customs Enforcement has halted most vehicle stops nationwide after agents fatally shot Johan Sebastián Durán Guerrero in Maine and Lorenzo Salgado Araujo in Houston. The shootings have renewed scrutiny of ICE tactics and delays in the Department of Homeland Security's body camera rollout. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Onda tropical 18 provocará lluvias intensas y posible ciclónEdomex entrega maquinaria para rehabilitar 340 kilómetros de callesFrancia mantiene 37 departamentos en alerta máxima por calorMás información en nuestro Podcast#grc

Efesios 1:1-13 I Pastor Ruben Guerrero 

La noche del 26 de septiembre de 2014 en Iguala, Guerrero, murieron tres estudiantes de la Normal de Ayotzinapa.

SMN prevé lluvias intensas y calor extremo para este viernesProfepa clausura predios por daños ambientales en ChiapasSomos México y Paz se incorporan formalmente al Consejo General del INEMás información en nuestro Podcast#grc

Ante el desplazamiento de los futbolísticamente menos desarrollados de América y África, la única probabilidad de identificación restante y aceptable para el resto de los suspirantes por la alternancia en el balompié es la Noruega de Haaland

The Strange Disappearance of David GuerreroBecome a supporter of this podcast: https://www.spreaker.com/podcast/missing-persons-mysteries--5624803/support.

Alertan por mar de fondo en costas del PacíficoCFE busca cobertura eléctrica nacional en 2028Economistas piden retirar sanciones contra Venezuela Más información en nuestro Podcast#grc

Adams v. Guerrero

La Suprema Corte de Justicia falló a favor de Abelina López Rodríguez e invalidó el informe realizado por la Auditoría Superior de Guerrero en el que se le señaló de un probable daño al erario por no comprobar el destino de la millonada...

SCJN invalida auditoría estatal contra AcapulcoCuba avanza en la recuperación del sistema eléctricoColombia brilla por sus esmeraldas y su historia Más información en nuestro Podcast#grc

Hallan sin vida al activista ambiental Alex Serna en Guerrero  Papa León XIV rinde homenaje a migrantes en Lampedusa  Egipto creó el calendario de 365 días por la crecida del Nilo  Más información en nuestro podcast#grc

Sheinbaum realizará gira por Michoacán Suspenden Muévete en Bici por copa mundialistaOla de calor desata compras de pánico en FranciaMás información en nuestro podcast#grc

¡Prepara tu paraguas! Las lluvias seguirán  Trabajadores de Pemex investigados por huachicolOMS alerta por riesgo de brotes en Venezuela  Más información en nuestro podcast#grc

Hosted on Acast. See acast.com/privacy for more information.

Rapid advances in acute ischemic stroke care have expanded treatment windows and improved patient outcomes through thrombolysis, mechanical thrombectomy, and optimized antithrombotic strategies. This episode highlights evolving approaches to patient selection, the growing role of tenecteplase, and the importance of team-based systems of care in delivering timely, effective treatment. In this episode, Casey S. Albin, MD, FAAN, speaks with Christopher R. Leon Guerrero, MD, author of the article "Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Leon Guerrero is an associate professor of neurology and the adult neurology residency program director at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, where he also serves as outpatient stroke director. Additional Resources Read the article: Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Albin: In stroke care, every minute kills nearly two million neurons. But today, we're going to unpack all the details about the latest treatments that can give those neurons back.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Albin: Hello and welcome. This is Dr. Casey Albin. Today, I'm interviewing Dr. Christopher Leon-Guerrero about his article on Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast. I always like to start by just having you introduce yourself so our listeners know a little bit about you.  Dr Leon-Guerrero: Thanks for the introduction, Dr. Albin. Really glad to be here today. My name is Chris Leon-Guerrero. I'm a vascular neurologist at Atrium Health in Charlotte, North Carolina, at Carolinas Medical Center. I'm an associate professor in the Department of Neurology. I serve as our Neurology Residency Program Director, and I also wear the hat of an outpatient stroke director in our clinics.  Dr Albin: So, you are wearing a lot of hats and balancing a lot of things, and it's a really exciting time to be talking about this. For our listeners, we are recording this right after the launch of the American Heart Association, American Stroke Association just released their new guidelines on acute ischemic care. So, no better time to kind of dive into some of this. And really, when I think about acute ischemic stroke care, it's dramatically transformed in the last two to three decades. I mean, from lengthening time windows for IV thrombolysis to expanded thrombectomy eligibility, this is really, I think, some of the most exciting stuff in neurology. And your article did a fantastic job of distilling those rapid advancements and clarifying some of the evidence behind some of these new evolving treatment selections and imaging modalities, and it's exciting. So, let's just start with thrombolysis. Where are we now with IV thrombolytics and the time windows there?  Dr Leon-Guerrero: So, a lot has changed in the last decade, since that initial trial with NINDS, nearly thirty years ago. We're still giving intravenous thrombolysis in the traditional time window up to 4.5 hours, and really emphasizing we should be selecting patients for treatment early and quickly as possible. In most of those cases, a non-con head CT is sufficient to rule out bleeding and initiate treatment as quickly as possible. Where things have gotten really exciting is using advanced neuroimaging to help select patients beyond that traditional 4.5 hour window, and we're able to treat patients even up to twenty-four hours from symptom onset.  Dr Albin: Which is really exciting. It has really totally shifted the paradigm here. You know, I think most listeners are going to be pretty familiar with three to four and a half hours. Like, that's sort of our standard. What can you tell us about some of the advanced imaging we're using for that later selection period?  Dr Leon-Guerrero: It's around the principle of you want to be able to, uh, rescue significant salvageable tissue without a lot of core. So, this large profusion deficit and small core is really how you're trying to select out these patients. And two types of modalities are used. One is going to be MRI, and a lot of those imaging protocols, you know, are outlined in the WAKE UP trial and basically are looking for patients with DWI hyperintense lesions and FLAIR negative lesions to suggest that patients in an early time window that's treatable for thrombolysis. And then in the other category, we'll be using profusion imaging, whether that's CT profusion or MR profusion, to look for patients with large salvageable tissue.  Dr Albin: Yeah. And I think that this has been one of the things that, to me, has been really impactful is I think when WAKE UP came out, it was exciting. It was fun to sort of think about, "Hey, we're going to be able to use MRI." But MRI can be very challenging to get acutely, especially in community centers where they don't have the capabilities to get someone from the emergency department into an MRI rapidly enough to make thrombolysis decisions. So, to see some of that expand to CT profusion has been really exciting. How are you going about sort of counseling patients or thinking about their risk when you're using some of those, like, advanced imaging techniques?  Dr Leon-Guerrero: Yeah. I think it's similar to the conversations we've had with patients even within the traditional 4.5 hour window. The risk for intravenous thrombolysis is hemorrhage, and counseling patients on the, you know, the risk and benefits of hemorrhage and the potential clinical benefit of receiving thrombolytics is important. And then providing patients with that information to make an informed decision, so that they can make the best decision for their own care.  Dr Albin: Totally. And it's, again, time sensitive, but trying to give families enough information and enough time to sort of process those, especially when it's a little bit beyond the standard that we're so used to consenting for. The other big area that's really changed is that tenecteplase has become the star of the show. It's really gained momentum, so what should clinicians understand about this?  Dr Leon-Guerrero: Yeah. There's been an explosion of data over the last decade on tenecteplase supporting its use for clinical practice. You know, there was recent updates even from the neurology journal with a large meta-analysis with all of the data showing good clinical outcomes and perhaps even lower risk of bleeding. And so, I think you're seeing a lot of centers across the country switching from alteplase to tenecteplase. There's some practical advantages. So tenecteplase is a one-time bolus dose. And then biologically, it seems to have better fibrin specificity, longer half-life, which may ultimately make it a more attractive drug and may make it even more effective. But I think the practical aspects of tenecteplase are not to be understated. I think there's a lot of advantages for speed and efficiency and for centers to make that switch.  Dr Albin: Yeah. I remember when our health system made the pivot from alteplase to tenecteplase. Like any changes, that obviously created some adjustments with the new workflow. But, the fact that this could be given just as a one-time dose and not with the "we got to calculate the bolus, and now we got to get the infusion on board," like really simplified workflow. So, I think that's been pragmatically one of the nicest things we've done in stroke care. Really exciting.  Dr Leon-Guerrero: Yeah. And, you know, it's a doable thing. I think you have to be, very deliberate about it at whatever center you're at to make sure that all stakeholders are aware of that change. I think that's helpful to get everybody involved and have a lot of planning to avoid wrong dosing errors or inadvertently dosing as alteplase versus tenecteplase. But it's certainly doable, and I think in the long term, centers that have switched have been pretty satisfied with tenecteplase.  Dr Albin: And you know, initially when this came out, there really was sort of a debate about, is it gonna be 0.25? Was it gonna be 0.4? Where have we landed with that debate?  Dr Leon-Guerrero: So, I think we found the correct dose is 0.25 milligrams per kilogram is the recommended dose with a max out of 25 milligrams. There's some within the American Heart Association guidelines that were just published. They mentioned even tier dosing based on 10 kilograms, so intervals. So, that may be an easier way for centers to do it. But that cap out dose of 25 milligrams at 0.25 milligrams per kilogram, I think, is the sweet spot.  Dr Albin: Yeah. That's great, and I think that that has helped, you know, say, "This is what we're doing. There's not a debate that's happening anymore." And that really just got codified in the new ASA guidelines, so really exciting there. So, there is a lot of guidance for these patients, but I think one of the things that your article really tackled is the fact that there are some special populations, where we really still don't have a lot of guidance. And so, I think just to kind of distill those for the listeners, thinking about our pregnant patients, thinking about children, how are we approaching thrombolysis decisions in these special populations?  Dr Leon-Guerrero: These are always tough cases. For example, for pregnant women, they've often been excluded in the thrombolytic trials. But there's still evidence. You know, there's some inference based on the evidence we do have, and there's a lot of registry and case reports suggesting potential safe treatment for pregnant women. And I think when you're approaching those cases, again, it's gonna be patient-centered and really should be multidisciplinary. These are the types of cases you really need to lean on your maternal fetal medicine colleagues, your high-risk OBGYNs, your obstetricians to help with that decision-making. And I think, a multidisciplinary approach is the way to go for these cases. It's the same thing with the pediatric population. We had some data. There was one trial, randomized control trial, called TIPS trial that looked at using intravenous alteplase for acute ischemic stroke in patients under the age of 18. It had difficulty with enrollment. But I think most experts would argue that patients with pediatric stroke should be considered for intravenous thrombolysis if appropriate. Again, same thing. You want to make it a multidisciplinary approach, really getting your pediatric neurologists, your pediatricians involved early to make the best decision for the patient.  Dr Albin: Yeah. That's just really an important takeaway, just thinking about this as a multidisciplinary decision, because there are going to be other stakeholders to the patient's care who may have some different information than what we as neurologists are bringing to the approach. And obviously, our perspective really matters. But trying to work in everyone's unique vantage point of the patient really helps to make the most effective decision. When we talk about acute ischemic stroke care, I really don't think that you could do justice to the topic without pivoting to mechanical thrombectomy, which, you know, as we think about how the medical field as a whole, not just neurology, how the medical field has evolved. I mean, there's probably no bigger impact than mechanical thrombectomy has made in terms of reducing not just morbidity, but mortality from stroke. I mean both. So, thrombectomy has been around for a while, but just walk our listeners through what's the core that we for sure know that these are the patients that this works for?  Dr Leon-Guerrero: The types of patients we should be selecting for intervention are patients with large vessel occlusions. And those initial trials that were published in 2015 really demonstrated that this is a quite an effective treatment for patients with large vessel occlusion ischemic strokes in the anterior circulation. When that smattering of publications occurred in 2015, the general consensus, we should be treating all patients up to six hours from symptom onset if they do have a large vessel occlusion. And then, Dr. Albin, as you know, the, the windows continue to expand. So, we were using advanced neuroimaging with MR selection and perfusion selection based on DAWN and DEFUSE 3 trial protocols to select patients all the way out to the 24 window, and it's even expanded beyond that over the last few years.  Dr Albin: I think that when we think about trials that really, totally, changed the game, when we think about DAWN and DEFUSE 3, and we switched from that time-based window to more of that, like we talked about for thrombolysis, that tissue-based clock and, like, looking at what is salvageable and where can we make an impact on salvageable tissue, truly moved the needle in terms of just bringing this therapy for people who, you know, it's hard to get in within six hours. When we moved the needle to 24, it made a huge difference. But people were still coming in with a lot of ischemic damage already done, and they would have traditionally been excluded from being enrolled in thrombectomy trials. But that's changing too. So where are we there?  Dr Leon-Guerrero: Yeah. I think there were lessons learned from DEFUSE and DAWN that we were probably over-selecting. Perhaps too stringent. You know, we had number needed to treat in the range of two to three for good outcome based on those trials. And so, I think those were lessons learned to move forward, and we, and, and people started looking at large core infarctions. And in the last few years, we've seen a multitude of randomized control trials examining large core infarctions. These are patients with ASPECT scores all the way down to zeros. A lot of the trials relied on three to six as their score, but there was at least one large core study that looked at ASPECT scores down to zero to two, and all of these studies showing benefit.  Dr Albin: Yeah. And we've really moved into if there's some tissue to spare there, probably getting clot out really makes a big difference in impact. You know, it was really surprising to me as a neurointensivist looking at these trials, that the trials had such low rates of hemorrhage, and pretty low rates of dramatic cerebral edema after thrombectomy. I don't know that we've seen all of that in sort of real world applications, but again, we are still seeing some of these patients come in, that really would've been devastated having some amount of functional recovery regained, which is incredible. In terms of another patient population that I think gives a lot of people pause or stickiness, is those basilar artery occlusions, right? Another large vessel, but one that we've had a little bit harder of a time enrolling in trials and having well-selected trials. Where are we now on whether or not basilar artery occlusion should go to mechanical thrombectomy?  Dr Leon-Guerrero: So, a lot of excitement in this area, too. There's at least two studies that were published in the last five years that were showing benefit in doing thrombectomy for patients with basilar artery occlusion up to 24 hours, and these were patients with moderate to severe deficits with NIH Stroke Scale scores greater than 10. And then making sure that they don't have large core, so using a newer scoring algorithm on the CAT scan called PC ASPECT, so basically a posterior circulation ASPECT score, to kind of make sure that patients don't have large core infarctions that are being considered for thrombectomy. All of those things collectively in those two recent studies, the ATTENTION trial and the BAOCHI trial, I think is what ended up making those studies positive, is that we were selecting the right types of patients, uh, without large core, early core, and patients with moderate to severe deficits that made the difference from previous trials.  Dr Albin: Yeah. I think that that's so important. Those trials to me, and like how long it took to get those enrolled, really emphasized to me that there really was a selection bias. Like, we believed this worked, which made it hard to then do a trial. But I'm so glad to hear that we have the data now to support moving forward in a more rigorous way.  Dr Leon-Guerrero: You're absolutely right. I think that was some of the challenges with the initial trials. In fact, the authors had commented on that. There's a lot of difficulties with lack of clinical equipoise, or experts wanting to take these patients anyways out of clinical trial and treat them, and so that's always been an issue. And then, you know, we all remember basilar artery occlusion cases. They can be severe, devastating cases in our career, but the reality is they're not that common. So, if you look at large vessel occlusions, they only account for about 10%, and if you look at all stroke patients presenting to most centers, they represent about 1% of cases. So really hard clinical trials to do just because there's thankfully not a lot of patients walking around with basilar artery occlusions, but certainly makes for challenges when you're trying to conduct randomized controlled trials on this subset of patients.  Dr Albin: Absolutely. But we did it, and I think that, like, really if, if the listeners take nothing else, it's that the field of vascular neurology is really moving forward with evidence-based, doing very rigorously controlled clinical trials, which is, I think, is what makes this field so exciting. Finally, closing out, cause we could talk all day, but we don't have all day. You know, it seems to me that more and more we are just using dual antiplatelet therapy all the time. And maybe that is, uh, a little bit of a hyperbole, cause I don't think it's all the time, but let's walk through— when is there good evidence for dual antiplatelet therapy?  Dr Leon-Guerrero: Yeah. So, there's strong evidence for early initiation of dual antiplatelet therapy or DAPT in patients with minor stroke or high-risk TIAs, and it's been studied using both clopidogrel as an add-on to aspirin and ticagrelor. Both seem like they're viable options in patients. I think one of the key things is the duration of therapy. So, in these cases with minor stroke and high-risk TIAs, we really should be confining the treatment of early DAPT for 21 days. The risk profile changes, so the risk of recurrent stroke starts to decline with time, and that risk of hemorrhage complications increases with time. And so that sweet spot of 21 days, or even some centers will do 30 days for just practical purposes, you know, really is what we should be doing in most of those cases. Other instances where DAPT can be considered, is in patients with intracranial atherosclerosis that's symptomatic, extrapolating from the SAMMPRIS trial that in the, in the medical management arm alone, used dual antiplatelet therapy with aspirin and clopidogrel for up to 90 days. So, you'll see that as well in clinical practice. Some people will opt for a 90-day duration for those patients with symptomatic intracranial atherosclerosis and stroke.  Dr Albin: Just so I emphasize, this is not set it and forget it. You can stay on DAPT forever. It is you're going to have a definitive time course, 21 days, 90 days. We have directed instructions where we're doing more benefit than harm because of that risk of hemorrhage.  Dr Leon-Guerrero: That's correct. In most cases, we really should be confining the duration of DAPT either to 21 days or 90 days. This is a challenging clinical practice. Centers really have been making an emphasis on stroke follow-up, so making sure these patients get appropriate and timely stroke follow-up to address these issues and to make sure that DAPT is discontinued if appropriate.  Dr Albin: Yeah. I love that, and I want to pull on that a little bit because you as someone who is helping direct a stroke center– A lot of this really does rely on systems of care. When we think about early lysis decisions or mechanical thrombectomy, it's how do we get the patient to one of those capable centers as quickly as possible? And then on the back end, when you're discharging a patient, how do you make sure that they are getting follow-up, making sure that they're getting their Holter monitor if they need it? You know, all the stuff that goes into kind of figuring out, why did the stroke happen? What are some of the things that you, in your role, are really excited about, that will move the needle over the next five or 10 years?  Dr Leon-Guerrero: Yeah. I think a lot of centers are doing it just like we're doing it. It really has to be a team-based approach, and you really want to reach the patient where they are in terms of the continuum of care. And so making sure if it's the in the field that you've reached out to your EMS and first responders to make sure they understand triage protocols to get patients where they need to be, to get the acute treatments that they need for the type of stroke that they're presenting with, to the actual centers that you work at, making sure your whole team, nurses, emergency physicians, APPs that are involved in care are all aware of the stroke protocols and how we're selecting these patients, making sure that your imaging protocols are up to date, and so that it's seamless when patients come in, that we're not adding on perfusion if we should have gotten that up front– We already know, have made decisions before that patient gets there. And then thinking about the patient after that hospital stay, I think, is critical. We really want to reduce their risk of recurrence, making sure that we're leveraging transitions of care, getting those patients seen in our stroke clinics for follow-up, and then make sure we're passing that baton to the long term. All of their long-term comorbidities that may be increasing their risk of stroke are managed and reduced as best as possible.  Dr Albin: From the Continuum journal to the continuum of stroke care.  Dr Leon-Guerrero: That's right.  Dr Albin: I mean, we have it all. I think that that really is so important. I'll just close with what's one thing that is your favorite part about being a vascular neurologist?  Dr Leon-Guerrero: I think it's what attracted to me to this field. As a medical student at that time, all we had was intravenous thrombolysis, and there was so much promise. There was so much promise that there was going to be widespread advancements in acute stroke, and here we are. There's been a tremendous amount of advancements and improvements for patients. I'm really excited to see what unfolds in the next few years, and I'm really excited that we've been able to increase the number of patients we're able to treat with acute ischemic stroke. I hope that we continue to expand the time window, the inclusion criteria, all of those things that we can treat more stroke patients effectively.  Dr Albin: It is really a very exciting time to be a vascular neurologist. Again, today, I've been interviewing Dr. Christopher Leon-Guerrero about his article on Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you again, Dr. Leon Guerrero and our listeners for joining today.  Dr Leon-Guerrero: Thanks for having me.  Dr Monteith: This is Dr. Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Victoria Guerrero, escritora, conversa con Glatzer Tuesta en el Bloque Cultural de No Hay Derecho de Ideeleradio. No Hay Derecho en vivo de lunes a viernes, desde las 7 a. m., por el YouTube y Facebook de Ideeleradio.

Andrew Guerrero, a 20-year-old active-duty military member, faces six counts of Rape of a Child in the second degree and two counts of first-degree Trafficking after Vancouver Police found two teen girls — ages 13 and 16 — living in his hotel room. Guerrero allegedly met the victims on social media. https://www.clarkcountytoday.com/news/vancouver-police-arrest-male-for-sex-crimes-against-teens/ #VancouverWA #ClarkCounty #PublicSafety #ChildTrafficking #OnlineSafety #VancouverPolice #SexCrimes #ChildProtection #CriminalJustice #WashingtonState

Joe Maddon and Tom Verducci discuss the struggles of the Mets this season and problems with the team that may not be apparent. Joe wants to know why league stats are so mediocre while new methods of teaching with analytics are supposed to be so much better. Tom points out the shocking turnover with managers in MLB. Tom asks Joe about the current state of the Angels and what elements of success have been missing for a long time. Plus, what can the Blue Jays do to help fix the issues of Vladimir Guerrero Jr.? The Book of Joe Podcast is a production of iHeart Radio. #fsrSee omnystudio.com/listener for privacy information.

Joe Maddon and Tom Verducci discuss the struggles of the Mets this season and problems with the team that may not be apparent. Joe wants to know why league stats are so mediocre while new methods of teaching with analytics are supposed to be so much better. Tom points out the shocking turnover with managers in MLB. Tom asks Joe about the current state of the Angels and what elements of success have been missing for a long time. Plus, what can the Blue Jays do to help fix the issues of Vladimir Guerrero Jr.? The Book of Joe Podcast is a production of iHeart Radio. #fsrSee omnystudio.com/listener for privacy information.

Se trata de un escrito de Juan Guerrero Zamora que nunca vio la luz y se estrenará en el Festival Internacional de Teatro Clásico de Mérida. Será la primera vez que la actriz se enfrente al escenario romano en lo que es también un homenaje a su madre.

Onda tropical 13 traerá lluvias intensas Venezuela prolonga suspensión de clases Países Bajos busca su primer título mundialista Más información en nuestro Podcast#grc

PIB alcanzará 1.3% en 2026: Banamex Cae implicado en asesinato de colaboradores de BrugadaCNPC alerta por inundaciones y deslaves en varios estadosMás información en uestro podcast#grc

Tema del Día: Los mejores lugares para el after!! En entrevista Carlos Speitzer y Alexa Martín, quienes vienen a platicarnos de La Pasión del Estadio Llega al Escenario: Eaenica estrena "El día que México ganó el mundial" protagonizada por Alexa Martín y Carlos Speitzer en teatrería. Viernes de Mal Viajarnos con los estragos del estrés. Odontóloga Lucía Guerrero.See omnystudio.com/listener for privacy information.

No lleves mascotas a los eventos del MundialEntregan apoyos a mujeres migrantes en JuárezSEGOB impulsa acuerdos con comunidades minerasMás información en nuestro Podcast#grc

This episode is brought to you by the Pick the Flick tier on our patreon. So, everyone, thank Soggy Bottoms for paying for the episode! Thanks Soggy! Vanessa joins Michael and Abe to talk about the hitman comedy/drama from 2008: In Bruges. Written and directed by Martin McDonagh, the three discuss the writing, themes, and jokes of this award winning film. Features: Vanessa Guerrero: https://bsky.app/profile/nessguerrero.bsky.social Michael Swaim: https://bsky.app/profile/michaelswaim.bsky.social Abe Epperson: https://bsky.app/profile/abeepp.bsky.social Support Small Beans and access Additional Content: https://www.patreon.com/SmallBeans Check our store to buy Small Beans merch! https://www.teepublic.com/stores/the-small-beans-store

SCHEDULE JBS, 6-15-20262006 MOLDOVABill Roggio discusses a rumored memorandum of understanding between Washington and Tehran. Roggio expresses skepticism, noting that while the Strait of Hormuz may reopen, the deal fails to address Iran's nuclear program or its support for regional proxies like Hezbollah. (1)Bill Roggio highlights that the ceasefire is a return to the status quo from February. He argues that the military was restrained from finishing the job and doubts the Iranian people's willingness to overthrow the regime. Meanwhile, Hezbollah remains active in southern Lebanon. (2)Ernesto Araújo and Alejandro Peña Esclusa report that in Peru, Keiko Fujimori leads the presidential race, signaling a "blue wave" against narco-socialism. This shift reinforces regional efforts like the Shield of the Americas. Meanwhile, Bolivia faces a "slow-motion coup" by narco-terrorists, which Brazilian President Lula da Silva has largely ignored. (3)Ernesto Araújo and Alejandro Peña Esclusa describe how U.S. forces killed drug lord "El Niño Guerrero" with a drone strike inside Venezuela, signaling a transition and military cooperation against the Tren de Aragua cartel. This action pressures regional leaders and criminal gangs, potentially leading to pro-democratic elections and increased American investment. (4)Bill Roggio warns that Sunni jihadists remain a background threat while the West focuses on Iran. Groups like al-Qaedaand ISIS are gaining ground in Africa and Afghanistan, aiming to establish emirates. Pakistan also faces instability as the Taliban provides safe havens for militants. (5)Ahmad Sharawi discusses President Trump's suggestion of using the Syrian army to conduct strikes against Hezbollahin eastern Lebanon. This "creative solution" aims to disarm the proxy without using the IDF. However, experts warn this could cause a "rally around the flag" effect and increase sectarian tensions. (6)Piero Tozzi and Gordon Chang discuss KMT official Jen Wen, who visited the U.S. to bolster her credentials but faced criticism for meeting individuals linked to the Communist Party. The visit highlighted debates over drone supply chains, as the U.S. encourages "non-red" technology to counter Chinese influence. (7)Fraser Howie and Gordon Chang describe the Iran deal as a "repackaging of failure" and a humiliation for America. Markets are experiencing a relief rally due to AI and stabilizing oil prices, but fail to price in geopolitical damage. Allies now view the U.S. as an unreliable partner. (8)John Hardie reports that Russia launched a massive barrage of 70 missiles and 600 drones against Kyiv, damaging a historic monastery. Simultaneously, Ukraine is conducting a "logistics lockdown" campaign to isolate Crimea by striking fuel convoys and bridges. Despite Russian gains near Kostiantynivka, Ukraine's manpower reforms are improving battlefield stability. (9)John Hardie notes that Jared Kushner and U.S. envoys have frequently visited Moscow to negotiate an end to the Ukraine conflict. Putin uses phone calls to flatter Trump and promote the idea that Russia is dominating the battlefield. The administration pressures Ukraine to concede Donbas, despite the military defense holding. (10)David Daoud explains that reports of an upcoming memo of understanding between the U.S. and Iran are contradicted by Israel's refusal to leave Lebanon. Iran aims to save Hezbollah, its most critical asset, while the U.S. seeks a modus vivendi with the regime at almost any cost. (11)David Daoud describes a ceasefire deal requiring Hezbollah to withdraw north of the Litani River as "magical thinking" since the fighters are locals. While the IDF faces manpower limitations, Washington continues to pressure Prime Minister Netanyahu to accept a withdrawal regardless of Israeli security concerns. (12)Bridget Toomey notes that despite the U.S.-Iran memo of understanding, the Houthis remain a threat, recently firing a drone at Eilat. The group maintains autonomy and does not feel bound by ceasefires. They continue to ban Israelimaritime navigation in the Red Sea, aiming for economic and psychological damage. (13)Samuel Ben-Ur explains that the IDF controls 64% of Gaza, but Hamas remains in control of the remaining civilian population through torture and executions. The group refuses to disarm, as their existence is predicated on destroying Israel. Despite the elimination of top leaders, the organization's decentralized structure allows survival. (14)Edmund Fitton-Brown explains that a memorandum of understanding is expected to be signed in Geneva, focusing on freedom of navigation in the Strait of Hormuz. The deal includes a 60-day ceasefire but leaves critical issues like the nuclear file for later. Skeptics warn of secret annexes and deceptive Iranian propaganda. (15)Edmund Fitton-Brown notes that Russia and China view a ceasefire as beneficial for weakening U.S. influence and entrenching Iranian power. Experts argue the Islamic Republic will never negotiate away its revolutionary pillars, including its militias and nuclear shield. The deal provides a rest period for Iran to rearm for future assaults. (16)Three name corrections: John Hardy → John Hardie (9, 10) Bridget Tumi → Bridget Toomey (13) Samuel Bener → Samuel Ben-Ur (14)

Iran deal, Niño Guerrero, New York Knicks riots, Elon Musk, and Freddie from Germany headline today's A.M. Update. Trump posts on Truth Social that a deal with Iran is complete and the Strait of Hormuz is open, but Aaron recorded much of this episode before that post dropped — and his pre-deal analysis still stands, because nobody has seen the text, the Middle East is calling it a capitulation, and Aaron says pump the brakes either way. Tren de Aragua leader Héctor Rusthenford Guerrero Flores, known as Niño Guerrero, is killed in a U.S. military strike that Trump announced Friday with video. New York Knicks fans torch five school buses, injure ten NYPD officers, and shoot one person celebrating the NBA championship, and Aaron notes that PSG fans set the bar and New York said hold my degeneracy. Elon Musk becomes the world's first trillionaire after SpaceX's $75 billion IPO, AOC calls him unintelligent, Ro Khanna wants a 5% wealth tax that Aaron's math shows wouldn't cover half of one year of bachelor's degree tuition. Aaron closes with Aaronalysis on Freddie from Germany, the X account that went from thousands to half a million followers by driving through the American South for the World Cup and being blown away by Buc-ee's, Bass Pro Shops, stranger hospitality, and the Gulf Coast at sunset.